Back

Effect of improving utilization of guideline-directed medical therapy for heart failure.

19 May 2025 (10:00 - 11:00)
Organised by: Logo
Congress Presentation Part of: ePosters in chronic heart failure - treatment (1) Treatment HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Jose Luis Ferraro

Hospital Centre do Tamega e Sousa, Penafiel (Portugal)

7 More presentations in this session

Presentation thumbnail
Retrospective review of primary prevention implantable cardiac defibrillator insertions for heart failure with reduced ejection fraction
Doctor A. Khalid (Adelaide, AU)
Abstract Slides Video
Presentation thumbnail
Transcatheter edge-to-edge mitral valve repair: a meta-analysis of hospitalization outcomes in heart failure and secondary mitral regurgitation
Doctor E. Mata (Creixomil, PT)
Abstract Slides Video
Presentation thumbnail
A meta-analysis of quality of life outcomes after transcatheter edge-to-edge mitral valve repair in secondary mitral regurgitation
Doctor B. Lage Garcia (Guimaraes, PT)
Abstract Slides Video
Presentation thumbnail
Effective regurgitant orifice area and left ventricular volume impact on hospitalizations effects of transcatheter edge-to-edge mitral valve repair: a meta-regression analysis
Doctor B. Lage Garcia (Guimaraes, PT)
Abstract Slides Video
Presentation thumbnail
Stroke volume assessment by pocus in patients with heart failure undergoing electrical cardioversion to reverse atrial fibrillation to sinus rhythm
Mrs A. Freitas (Curitiba, BR)
Abstract Slides Video

Access the full session

Session thumbnail
ePosters in chronic heart failure - treatment (1)

The Event

Event poster

Heart Failure 2025

19 May 2025 10:00 CET
You may be interested in
thumbnail
Congress Presentation
Real-world data from registries
thumbnail
Congress Presentation
Initiation and titration of prognostic drug therapy during hospitalization for acute decompensation of heart failure with reduced ejection fraction
thumbnail
Congress Presentation
Optimising guideline-directed medical therapy in the sickest patients: how far can we go?

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources